Dr. Katherine A. Coerver, MD
Neurology (Behavioral Neurology & Neuropsychiatry Physician)
5975 S Quebec St Ste 150
Centennial, CO 80111
Who else practices at this address →
Arapahoe County includes primary care (8% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- Baylor College of Medicine (1998)
- Years since graduation
- 28
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 373
Licensed in Colorado since 2015, according to the Colorado Department of Regulatory Agencies. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1998Medical school: Baylor College of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Behavioral Neurology & Neuropsychiatry Physician primary
CO license DR0055149 (first issued 2015; active) -
Neurology Physician
MD license D0062115
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Adventhealth Littleton Littleton, CO
- Hca-Healthone DBA Swedish Medical Center Englewood, CO
- Adventhealth Castle Rock Castle Rock, CO
Medical groups
- Rocky Mountain Neurology PC (4 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 373
- Services billed
- 1,976
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| Administration of psychological or neuropsychological test, each additional 30 minutes | 231 | 46 |
| New patient office or other outpatient visit, 60-74 minutes | 150 | 150 |
| Established patient office or other outpatient visit, 40-54 minutes | 139 | 124 |
| Evaluation of neuropsychological test, each additional hour | 95 | 46 |
| Measurement of brain wave activity (eeg), awake and asleep | 87 | 87 |
| Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | 64 | 60 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 63 | 55 |
| Evaluation of neuropsychological test, first hour | 46 | 46 |
| Administration of psychological or neuropsychological test, first 30 minutes | 46 | 46 |
| Psychiatric diagnostic evaluation | 45 | 45 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 20 companies reported 131 payments worth $4,916 in total to this clinician.
| Biogen, Inc. | $1,899 |
|---|---|
| AbbVie Inc. | $797 |
| Eisai Inc. | $423 |
| Lilly USA, LLC | $382 |
| Axsome Therapeutics, Inc. | $259 |
| Lundbeck LLC | $187 |
| Pfizer Inc. | $166 |
| Argenx US, Inc. | $165 |
| Food and Beverage | $2,959 |
|---|---|
| Consulting Fee | $1,958 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Biogen, Inc. Aug 25, 2025 | Consulting Fee | $1,713 |
| Eisai Inc. May 9, 2025 | Consulting Fee Leqembi · Neurology | $245 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $202,377 in research payments for these studies, mostly to the institutions running them.
- A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)
Eli Lilly and Company · Active, not recruiting · NCT06653153
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.